India’s first dedicated life science and healthcare fund of $250 million has become one of the core investment themes for the venture capital firm.
In 2007, Eight Roads Ventures began its India operation will be used to invest the fund in 15-20 companies over three to four years, Prem Pavoor, senior partner, head of India and healthcare media, reported.
- Bharti Airtel Shares Slump 3% as Singtel Looking to Divest Stake
- Rail Vikas Nigam Shares Skyrocket 11% on Securing Award Worth Rs 115 Crore
- Overnight Stock Market Movements: Key Developments Impacting Markets
- Stocks Under F&O Ban: Manappuram Finance, Hindustan Copper, and OthersÂ
- Stocks in Focus: Rail Vikas Nigam, Infosys, Alkem Laboratories, and Others
“We are sub-segment agnostic, stage agnostic and investment size agnostic. We are happy to make small investments and even growth stage ones that will go up to $40 million,” he said.
The new fund will continue to follow its two-pronged strategy for investing in companies. First is the win-from-behind strategy that involves investment in segments established in healthcare which are largely pharmaceuticals and healthcare services. The second strategy is to invest in companies with an aim to build leaders in segments that are still nascent.
“Healthcare has always been a key focus for us at Eight Roads globally. About 40-45% of our investment has been in the healthcare sector, and the balance is in tech, consumer, fintech,” said Pavoor.
“The launch of this healthcare fund reflects our confidence in the evolution of the India market and our commitment to helping ambitious founders scale, “Daniel Auerbach, senior managing partner and head of global ventures at Eight Roads Ventures, said in a statement.
